Johnson & Johnson started a trial of its experimental Ebola vaccine in the U.K. and said it will produce 2 million courses of the shot this year. The first volunteers in Oxford have received an initial dose, and the trial aims to recruit 72 people by the end of January, the New Brunswick, N.J.-based company said in a statement.
J&J injects first volunteer in race to make Ebola vaccine
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content